Abilify Makers Warn of Compulsive Gambling Behavior in Canada But Not in United States

On November 2, 2015, Health Canada issued a Safety Alert advising physicians and patients of an increased risk of pathological gambling on Abilify.  Health Canada required the makers of Abilify to update its prescribing information to include a warning about uncontrollable impulses to gamble while on Abilify.* No such warning exists on the prescribing information for Abilify sold in the United States.

Abilify® might be causing compulsive or out-of-the-ordinary behavior in you or your loved one. As of July 2013, physicians in medical journals have reported at least eight cases of compulsive gambling in patients taking Abilify (aripiprazole). In all eight cases, when patients stopped taking Abilify, the strong urge to gamble also stopped. Other out-of-the-ordinary, compulsive behaviors reported by patients after beginning or increasing their dose of Abilify include: over-eating, over- shopping, and hypersexuality.  The Food and Drug Administration database shows many reports that Abilify patients have experienced compulsive behaviors, especially compulsive gambling.

At Robins Kaplan LLP, we investigate potential claims on behalf of Abilify patients to see if they may have an Abilify lawsuit case.  Our firm includes attorneys experienced in pharmaceutical lawsuits like Abilify. We are careful listeners and your story is important to us. Our on-staff medical advisors are available to answer your questions and listen to your concerns as you determine what to do next. If you think you or a loved one has been injured by Abilify, we are interested in hearing what you have to say.

For a free case evaluation, please call 1.800.553.9910 (toll-free) or fill out this form. Our legal nurse consultants are standing by.

What is Abilify?

You should understand the facts. Abilify, also known as aripiprazole, is usually prescribed to treat a variety of disorders including schizophrenia, irritability, agitation, depression and mania. Sometimes, it is prescribed for patients along with an anti-depressant (called a serotonin reuptake inhibitor) for more severe depressive disorders. Abilify was developed and manufactured by Otsuka Pharmaceutical Co., headquartered in Japan, and Bristol-Myers Squibb, headquartered in New York. Learn more about Abilify.

If you or someone you know has been prescribed Abilify and has developed a compulsive gambling addiction, compulsive eating addiction, compulsive shopping addiction or compulsive sex addiction, you may have an Abilify claim or an Abilify lawsuit. Please call 1.800.553.9910 or email us. Our dedicated team of attorneys is experienced in drug-related lawsuits.